Related Experiment Video
Updated: Oct 4, 2025

06:28
Isolation and Culture of Primary Oral Keratinocytes from the Adult Mouse Palate
Published on: September 24, 2021
6.3K
C-kit Expression in Oral Leukoplakia
Anand S Tegginamani1, Vanishree H Shivakumar1, Siti Mazlipah B Ismail2
1Faculty of Dentistry, SEGi University, Kota Damansara, Petaling Jaya, Selangor, Malaysia.
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
|February 2, 2022
Summary
C-kit expression was evaluated in oral leukoplakia (OL) to assess malignant transformation risk. The study found limited c-kit expression in OL, suggesting it may not be a unique high-risk marker.
Area of Science:
- Oral pathology
- Oncology
- Immunohistochemistry
Background:
- Oral leukoplakia (OL) is a common potentially malignant oral disorder with variable malignant transformation rates.
- Malignant potential of OL is independent of histopathological grade, influenced by ethnic and environmental factors.
- Accurate risk prediction for OL progression remains a challenge.
Purpose of the Study:
- To evaluate c-kit (CD 117) expression in oral leukoplakia (OL) using immunohistochemistry.
- To investigate the potential of c-kit as a marker for differentiating OL with high and low malignant transformation risk.
- To compare c-kit expression in OL with oral squamous cell carcinoma (OSCC) and dentigerous cysts (DC).
Main Methods:
- C-kit immunohistochemistry was performed on tissue samples.
- Samples included 15 oral leukoplakia (OL), 2 oral squamous cell carcinoma (OSCC), and 2 dentigerous cysts (DC).
- Expression patterns of c-kit were analyzed in the different oral lesions.
Main Results:
- Faint cytoplasmic c-kit expression was observed in basal cells of only four OL samples.
- Oral squamous cell carcinoma (OSCC) and dentigerous cysts (DC) samples showed no c-kit expression.
- The observed c-kit expression in OL was not consistently indicative of high-risk lesions.
Conclusions:
- C-kit (CD 117) expression in oral leukoplakia appears limited and may not serve as a unique marker for identifying lesions at high risk of malignant transformation.
- Further research with larger sample sizes is necessary to validate these findings.
- The study highlights the need for novel biomarkers for accurate risk stratification of oral leukoplakia.
Related Concept Videos
Cytoskeletal Linker Proteins - Plakins
2.5K
Plakins are large proteins with binding domains for microtubules, microfilaments, intermediate filaments, and membrane-associated protein complexes at cell junctions. Plakin functions are evolutionarily conserved and are primarily involved in organizing the different components of the cytoskeleton by crosslinking them to each other and connecting them to the cell-matrix and cell adhesion complexes. They are also known to interact with signal transducers, serve as scaffolds for signaling...
2.5K
Inhibition of Cdk Activity
5.0K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.0K
Induced Pluripotent Stem Cells
4.5K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.5K

